Natural plant extracts have long been the cornerstone of the health and skincare industries, but how can we overcome the limitations of traditional plant extracts—namely, their ‘low bioactivity, poor absorption and unclear mechanisms of action’? NVTIA provides a clear answer.

NVTIA specialises in the research and development of new raw materials and innovative ingredients, with its core scientific rationale deeply inspired by the research of Nobel Laureate Professor Gregg L. Semenza on ‘hypoxia-inducible factor (HIF)’. By precisely regulating the endogenous responses of plant extracts at the cellular level, NVTIA has successfully elevated the targeting and bioavailability of active ingredients to unprecedented levels.

Backed by 15 international PCT patents, every new ingredient from NVTIA has been rigorously validated through in vitro and clinical trials. From the directed catalytic extraction of rare plants to the application of internationally patented encapsulation technology, NVTIA is helping global brands bridge the gap between ‘all-natural’ and ‘highly effective’, establishing itself as the partner of choice for the registration and application of new ingredients.